Diskussionsleiter: M. Zarse (Lüdenscheid)
| (P547) | Association between initiation of ranolazine and recurrent ventricular tachycardia | |
| R. Kasabov, M. Grosch, R. Johna, M. Ferrari, J. Schumm (Wiesbaden) | ||
| (P548) | Obesity modulates the response to antiarrhythmic drugs in atrial fibrillation by downregulating the cardiac sodium channel | |
| S. Kany, M. McCauley, J. Rehman, E. Wißner, D. Darbar (Chicago, IL, US) | ||
| (P550) | First experience with the ultra-short acting intravenous cardioselective Beta-Blocker Landiolol on the intensive care unit in Germany: a case series | |
| K. Weinmann, P. Hartveg, D. Buckert, A. Pott, K. Petscher, A. Imhof, W. Rottbauer, T. Dahme (Ulm) | ||
| (P551) | Baseline characteristics among anticoagulated patients treated with edoxaban in Austria, Germany and Switzerland – Data Snapshot results from ETNA-AF study | |
| T. Vogtmann, K.-F. Appel, J. Taggeselle, F. Menzel, A. Wilke, C. Axthelm, U. Wolf, J. Walternberger, T. Weiss, J. Auer, A. Kober, P. Kirchhof, J. Steffel, für die Studiengruppe: ETNA (Potsdam, Kassel, Markkleeberg, Dessau-Roßlau, Papenburg, Pirna, Kleinmachnow, Münster; Wien, Braunau, St. Aegyd am Neuwalde, AT; Birmingham, UK; Zürich, CH) | ||
| (P552) | Erfolgreiche Behandlung eines Patienten mit katecholaminerger polymorpher ventrikulärer Tachykardie mit Propafenon über 35 Jahre | |
| A. Marx, C. Nalenz, B. Lange, H. Mollnau, B. A. Hoffmann, B. M. Quesada Ocete, R. Spittler, V. H. Schmitt, C. Kowalewski, P. Ilioska, M. Barone, P. M. G. Seidel, K. Steinbach, K. Bock, T. Rostock, T. Konrad (Mainz) |